MD Anderson Cancer Center

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
1	A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	Recruiting	Active	Ziftomenib + Imatinib	NCT06655246
	Gastrointestinal Stromal Tumors (GIST) Registry	Completed	Closed	None	NCT00507273
	Symptom Inventory for Gastrointestinal Stromal Tumors	Ongoing, but not recruiting	Closed		NCT01178307